Stay updated on ABO-102 Gene Transfer in MPS IIIA Clinical Trial
Sign up to get notified when there's something new on the ABO-102 Gene Transfer in MPS IIIA Clinical Trial page.

Latest updates to the ABO-102 Gene Transfer in MPS IIIA Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the ABO-102 study in patients with MPS IIIA is displayed, with study design, eligibility, outcomes, locations, and record history. It also includes study documents and notes that the trial was terminated due to lack of efficacy in patients with advanced disease.SummaryDifference60%

- Check13 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner was added announcing NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check27 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the study record remains unavailable behind the 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. This blocks access to the trial details and related information on the page.SummaryDifference20%

Stay in the know with updates to ABO-102 Gene Transfer in MPS IIIA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABO-102 Gene Transfer in MPS IIIA Clinical Trial page.